SCM
LNAI

Sterling Capital Management’s Lunai Bioworks LNAI Stock Holding History

Sterling Capital Management’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9
Closed -$407 – 3373
2025
Q1 		$407 Sell
9
-8
-47% -$512 ﹤0.01% 2997
2024
Q4 		$1.14K Buy
17
+16
+1,600% +$1.06K ﹤0.01% 2916
2024
Q3 		$43 Buy
+1
New +$69 ﹤0.01% 3244

Other funds holding LNAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Sterling Capital Management's LNAI Position: Q2 2025 in Review

Sterling Capital Management sold out of Lunai Bioworks (LNAI) in Q2 2025, closing a stake of 9 shares — an estimated $407 sold.

Sterling Capital Management first reported a position in LNAI in Q3 2024 and held it in 3 quarters. The position peaked at $1.14K in Q4 2024. 42 funds tracked by Wall St. Rank hold LNAI as of Q2 2025.

  • Sterling Capital Management reported no remaining Lunai Bioworks position as of Q2 2025 after selling out during the quarter.
  • Sterling Capital Management sold 9 Lunai Bioworks shares in Q2 2025, an estimated $407.
  • Sterling Capital Management first reported a position in Lunai Bioworks in Q3 2024 and held it in 3 quarters.
  • Sterling Capital Management's Lunai Bioworks position peaked at $1.14K in Q4 2024.
  • 42 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2025.

Based on Sterling Capital Management's 13F filing for Q2 2025, filed 6 Aug 2025.